Cover
Vol. 10 No. 1 (2020)

Published: December 31, 2020

Pages: 119-131

Research Article

Outcome of GnRH antagonist ICSI cycles triggered by GnRH agonist plus Recombinant hCG versus triggered with Recombinant hCG alone in fresh autologous ICSI cycle

Wafaa Mohammed Abed 1 Mohammed Oda Selman High Institute of Infertility Diagnosis and Assisted Reproductive Technologies Al Nahrain
1University, Baghdad, Iraq.
History
  • Received: October 9, 2020
  • Accepted: November 17, 2020
  • Available Online: December 21, 2020
DOI

https://doi.org/10.28969/IJEIR.v10.i1.r8

Abstract

To explore whether dual triggering for final oocyte maturation using a low dose of recombinant human chorionic gonadotropin (hCG) plus gonadotropin-releasing hormone agonist (GnRH-a) is as effective as the standard dose of recombinant hCG triggering alone in term of a total number of retrieved oocytes, fertilization and pregnancy rate in fresh autologous antagonist intracytoplasmic sperm injection (ICSI) cycles. 80 infertile women undergoing ICSI, aged ˂ 40 years, 18˂ Body mass index ˂30 Kg/m2 included in fresh autologous antagonist ICSI cycles. 40 women received a Standard dose of recombinant hCG (500 µg) alone and 40 women received GnRH-a (0.2 mg triptorelin plus 250 µg recombinant hCG) were used for final oocytes maturation. This study was conducted at the High Institute for Infertility Diagnosis and Assisted Reproductive Techniques, Al Nahrain University. The mean total number of retrieved oocytes, fertilization, and pregnancy rate were measured. The mean total oocyte number being statistically higher in the dual trigger group. The mean number of fertilized oocytes and clinical pregnancy rates was higher in the dual trigger group than in the control group, but the difference showed borderline statistical significance. Furthermore, fertilization rates show no statistical difference between the control group and the dual trigger group. Results of the study confirm that dual triggers show favorable improvement in fresh autologous antagonist ICSI cycles with the use of GnRH agonists plus hCG compared with hCG alone for triggering of final oocyte maturation.

Keywords

References

  1. Allegra A, Marino A, Volpes A, Coffaro F, Scaglione P, Gullo S, La Marca A. A randomized controlled trial investigating the use of a predictive nomogram for the selection of the FSH starting dose in IVF/ICSI cycles. Reprod Biomed Online. 2017;34(4):429-438. [Online Article Link]
  2. Behery MA, Hasan EA, Ali EA. Comparative study between agonist and antagonist protocols in PCOS patients undergoing ICSI: a cross- sectional study. Middle East Fertil Soc J. 2020;24(2). [Online Article Link]
  3. Griffin D, Feinn R, Engmann L, Nulsen J, Budinetz T, Benadiva C. Dual trigger with gonadotropin- releasing hormone agonist and standard-dose human chorionic gonadotropin to improve oocyte maturity rates. Fertil Steril. 2014;102(2):405-9. [Online Article Link]
  4. Lawrenz B, Garrido N, Samir S, Ruiz F, Melado L, Fatemi H. Individual luteolysis pattern after GnRH-agonist trigger for final oocyte maturatin. PLoS One. 2017;12(5):e0176600. [Online Article Link]
  5. El Tokhy O, Kopeika J, Ell-Joukhy J. An update on the prevention of ovarian hyper stimulation syndrome. Women ̓s Health, 2016;12(5):496-503. [Online Article Link]
  6. Eftekhar M, Naghshine E, Neghab N, Hosseinisadat R. A comparison of dual triggering (by administration of GnRH agonist plus HCG) versus HCG alone in poor ovarian responder in ART outcomes. Middle East Fertility Society Journal. 2018;23(4):350-353. [Online Article Link]
  7. Rosini R, Campisi E, De Chiara M, Tettelin H, Rinaudo D, Toniolo C. Genomic analysis reveals the molecular basis for capsule loss in the group B streptococcus population, PLoS One. 2015;10:e0125985. [Online Article Link]
  8. Vuong LN, Pham TD, Ho VNA, Ho TM, Humaidan P, Andersen CY. Determinants of the hCG concentration in the early luteal phase after final maturation of follicles with bolus trigger of recombinant hCG. Front. Endocrino. 2020;11:137,1-7. [Online Article Link]
  9. Mohammed A, Woad KJ, Mann GE, Craigon J, Rain-fennig N, Robinson R. Evaluation of progesterone supplementation for luteal phase support in fresh in vitro fertilization cycles. Fertility and Sterility. 2019;112(3):491-502.e3. [Online Article Link]
  10. Humaidan P, Kol S, Papankolaou, EG. GnRH agonist for triggering of final oocyte maturation: Time for a change of practice? Hum Reprod Update. 2011;17:510-524. [Online Article Link]
  11. Griesinger G, Diedrich K, Devroey P, Kolibianakis EM. ‘GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis’, Hum Reprod Update. 2005;12(2):159– 68. [Online Article Link]
  12. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Thomas S. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertil. Steril. 2008;90(1)231-233. [Online Article Link]
  13. Griffin D, Engmann L, Budinetz T, Kummer N, Nulsen J, Benadiva C. Dual trigger with gonadotropin releasing hormone agonist (GnRHa) and human chorionic gonadotropin (hCG) for the treatment of 'immature oocyte syndrome'(IOS). Fertil Steril. 2012;98(3):S156. [Online Article Link]
  14. Lin MH, Wu FS, Lee RK, Li S, Lin S, Hwu Y. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles, Fertil. Steril. 2013;100(5):1296-1302. [Online Article Link]
  15. Haas J, Ophir L, Barzilay E, Machtinger R, Yung Y, Orvieto R, Hourvitz A. Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot study, Fertil Steril, 2016;106(3):653–659.e1. [Online Article Link]
  16. Lin MH, Wu FS, Hwu YM, Lee RK, Li RS, Li SH. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve, Reproductive biology and endocrinology, 2019;17(1):7. [Online Article Link]
  17. Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger, D Bern O. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study, Fertil Steril, 2008;90(4):1087–1093. [Online Article Link]